729 related articles for article (PubMed ID: 17823524)
1. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
4. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
Baglieri F; Scuderi G
Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
7. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
Nybaek H; Jemec GB
Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
[No Abstract] [Full Text] [Related]
8. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
9. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
10. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.
Swale VJ; Saha M; Kapur N; Hoffbrand AV; Rustin MH
Clin Exp Dermatol; 2005 Mar; 30(2):134-6. PubMed ID: 15725238
[TBL] [Abstract][Full Text] [Related]
11. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
12. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
Cocco A; Angelucci E; Viscido A; Caprilli R
Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
[No Abstract] [Full Text] [Related]
13. Favorable response to infliximab treatment in a patient with active Crohn disease and pyoderma gangrenosum.
Triantafillidis JK; Cheracakis P; Sklavaina M; Apostolopoulou K
Scand J Gastroenterol; 2002 Jul; 37(7):863-5. PubMed ID: 12190104
[TBL] [Abstract][Full Text] [Related]
14. Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?
Adişen E; Oztaş M; Gürer MA
Dermatology; 2008; 216(2):163-5. PubMed ID: 18216480
[TBL] [Abstract][Full Text] [Related]
15. Rapid improvement of pyoderma gangrenosum after treatment with infliximab.
Chan JL; Graves MS; Cockerell CJ; Pandya AG
J Drugs Dermatol; 2010 Jun; 9(6):702-4. PubMed ID: 20645536
[TBL] [Abstract][Full Text] [Related]
16. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
[TBL] [Abstract][Full Text] [Related]
17. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
[TBL] [Abstract][Full Text] [Related]
19. [Pyoderma gangrenosum with an atypical location and a rapid response to cyclosporin A].
Ferrer Ríos T; Ramos Lora M; Pallarés Manrique H; Pérez Gómez MB; Garrido Mora M; Carrasco FJ; Domínguez Macías A
Gastroenterol Hepatol; 1999 May; 22(5):227-9. PubMed ID: 10396103
[TBL] [Abstract][Full Text] [Related]
20. Superficial granulomatous pyoderma treated preoperatively with infliximab.
Akhras V; Sarkany R; Walsh S; Hyde N; Marsden RA
Clin Exp Dermatol; 2009 Jul; 34(5):e183-5. PubMed ID: 19094137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
